CHEST Physician
-
Beyond the blueprint: Early outcomes from the CHEST Critical Care APP certification exam
The 2025 exam tells a clear story: APPs are seeking meaningful validation, value lifelong learning, and want credentials that reflect the realities of modern critical care.
-
The burden of post-TB lung disease
Post-TB lung disease causes substantial long-term respiratory morbidity, disability, and increased mortality among TB survivors worldwide.
-
Mechanical power as a target for lung protective ventilation
Mechanical power-based strategies aim to minimize unnecessary power delivery and reduce harm. Review how to measure and use this metric and what challenges it poses.
-
New fund empowers CHEST Networks to pursue their most impactful ideas
The Networks Advancement Fund offers financial support for projects that directly advance CHEST’s philanthropic pillars while furthering the mission of an individual Network.
-
Top reads from the CHEST journal portfolio – February 2026
Read new research from the journal portfolio on obesity hypoventilation syndrome treatment, long volume reduction in severe emphysema, and anticoagulation management in cardiogenic shock.
-
Remembering a giant of chest medicine: Alfred Soffer, MD, Master FCCP
Alfred Soffer, MD, Master FCCP, served as Editor in Chief of the journal CHEST® from 1968 to 1993 and led CHEST as its Executive Director from 1969 to 1992.
-
GLP-1RAs may trigger chronic cough for some patients with diabetes
Surprisingly, the association between GLP-1 medications and chronic cough was stronger in patients without an existing diagnosis of gastroesophageal reflux disease.
-
Optimal synergy: Coupling smart wearable devices, sensors with AI algorithms
Coupling noninvasive wearable devices with AI-enabled data analytics helps to address two key challenges: health care access and improvement of patient-centric care.
-
De-escalating antibiotics proves safe for patients with community-onset sepsis
Ashwin B. Gupta, MD, addresses lingering clinician hesitancy surrounding the de-escalation of antibiotics for adults hospitalized for community-onset sepsis.
-
GLP-1RAs may reduce risk of asthma exacerbations for adolescents with obesity
Pulmonologist Farrukh Abbas, MD, said this observational study generates a hypothesis about the anti-inflammatory benefits of GLP1-RA medications in patients with asthma and obesity that needs to be confirmed in trials.
